Pharmaceutical Chemistry Journal

, Volume 28, Issue 9, pp 611–615 | Cite as

Reactivity and mechanism of action of triazenes XIII. Correlation of structure, reactivity, and biological activity of 3,3-dimethyltriazenes and other cryptodiazonium transport forms of cytotoxic diazo derivatives

  • V. I. Nifontov
  • N. P. Bel'skaya
  • L. V. Krupnova
  • Yu. A. Ershova
  • A. P. Fedorova
Molecular Biological Problems in the Design of Drugs and Study of the Mechanism of Their Action


Organic Chemistry Biological Activity Triazenes Transport Form Diazo Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. Bolis et al., Membranes and Disease [in Russian], Moscow (1980), p. 143.Google Scholar
  2. 2.
    V. I. Nifontov, N. P. Bel'skaya, V. A. Chernov, et al., Khim.-farm. Zh., No. 9, 1037–1044 (1984).Google Scholar
  3. 3.
    V. I. Nifontov, A. A. Rudnykh, L. A. Gorelova, et al., Quantitative Aspects of Chemical Influences in Oncology: Materials of the All-Union Symposium, St. Petersburg (1985), pp. 66–67.Google Scholar
  4. 4.
    V. I. Nifontov, L. V. Tat'yanenko, V. A. Chernov, et al., Khim.-farm. Zh., No. 5, 522–525 (1988).Google Scholar
  5. 5.
    V. I. Nifontov, N. P. Bel'skaya, V. A. Chernov, et al., Khim.-farm. Zh., No. 7, 773–776.Google Scholar
  6. 6.
    V. I. Nifontov, N. P. Bel'skaya, O. A. Belyakova, et al., Khim.-farm. Zh., No. 1, 63–65 (1990).Google Scholar
  7. 7.
    V. I. Nifontov, N. P. Bel'skaya, O. A. Bagaeva, et al., Khim.-farm. Zh., No. 4, 53–54.Google Scholar
  8. 8.
    V. I. Nifontov, N. P. Bel'skaya, L. V. Krupnova, and A. S. Barybin, Khim.-farm. Zh., No. 7–8, 18 (1992).Google Scholar
  9. 9.
    Pat. 2,008,750 USA. Chem. Abstr.,29, N 6078 (1935).Google Scholar
  10. 10.
    G. Abel, T. A. Connors, and T. Giraldi, Cancer Lett.,3, 259–264 (1977).Google Scholar
  11. 11.
    S. Garaffini and G. Franchi (eds.), Chemotherapy of Cancer: Dissemination and Metastasis, New York (1973), pp. 129–138.Google Scholar
  12. 12.
    P. J. O'Connors and G. P. Margison, NATO Advanc. Study Inst. Ser. A,40, 233–245 (1981).Google Scholar
  13. 13.
    S. L. Edvards, J. S. Sherfinski, and R. E. Marsh, J. Am. Chem. Soc.,96, No. 8, 2593–2597 (1974).Google Scholar
  14. 14.
    T. Giraldi, P. Y. Houghton, D. M. Taylor, and C. Nisi, Cancer Treat. Rep.,62, No. 5, 721–725 (1978).Google Scholar
  15. 15.
    G. F. Kolar and Y. Schlesiger, Cancer Lett.,1, 43–47 (1975).Google Scholar
  16. 16.
    D. Li, C. Giung, and X. Hao, Yiyao Gougue,17, No. 2, 63–65 (1986).Google Scholar
  17. 17.
    P. P. Saunders and L.-Yu. Chao, Cancer Res.,34, 2464–2468 (1974).Google Scholar
  18. 18.
    G. Sava, T. Giraldi, R. Cuman, et al., Current Chemotherapy and Immunotherapy: Proceedings of the 12th International Congress on Chemotherapy, Vol. 2 (1982), pp. 1329–1331.Google Scholar
  19. 19.
    G. Sava, T. Giraldi, L. Lassiani, et al., Biochem. Pharmacol.,31, No. 22, 3629–3634 (1982).Google Scholar
  20. 20.
    Y. F. Shealy, R. F. Struck, L. B. Holum, and Y. A. Montgomery, J. Org. Chem.,26, 2396–2401 (1961).Google Scholar
  21. 21.
    Ch. D. Stevens, J. A. Muhlenpoh, M. E. Turner, et al., Proc. Soc. Exp. Biol. (N.Y.),99, 64–67 (1958).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • V. I. Nifontov
    • 1
  • N. P. Bel'skaya
    • 1
  • L. V. Krupnova
    • 1
  • Yu. A. Ershova
    • 1
  • A. P. Fedorova
    • 1
  1. 1.Ékaterinburg. S. Ordzhonikidze Chemo-Pharmaceutical Scientific Research InstituteUrals State Technical UniversityMoscow

Personalised recommendations